19/02/2026
We’re proud to share that Alkem has been recognized with the “Most Promising Biologics Drug Pipeline” award at the Asia-Pacific Biopharma Excellence Awards 2026.
This honour, based on industry voting by 10,000+ professionals across the biologics, cell & gene therapy, and vaccine community, is a strong validation of our growing capabilities and commitment to advanced therapies.
The ABEA, held alongside the 16th Vaccines World Summit and 10th Biologics Festival India 2026, celebrates excellence across vaccine research, bioprocessing, supply chain, and biologics manufacturing.
Dr. Akhilesh Sharma, President & CMO – Alkem, represented Team Alkem at the ceremony and received the award on behalf of the organization.
A big thank you to our R&D, manufacturing, quality, regulatory, and cross-functional teams who are helping build a strong, future-ready biologics pipeline for Alkem.
This milestone belongs to Team Alkem. Onward and upward.
PharmaInnovation